XML 42 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation Arrangements (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Stock Appreciation Rights (SARs) [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 108,794    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (8,255)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 100,539 108,794  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 10.89    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 0.00    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 0.00    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price $ 15.42    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 11.14 $ 10.89  
Fair value of stock appreciation rights      
Dividend yield 0.00% 0.00% 0.00%
Expected life (years) 7 years    
Volatility 63.63% 80.66% 85.95%
Stock Appreciation Rights (SARs) [Member] | Minimum [Member]
     
Fair value of stock appreciation rights      
Risk Free Interest Rate 0.27% 0.40% 1.65%
Expected life (years) 2 years 2 months 3 years 2 months 4 years 2 months
Stock Appreciation Rights (SARs) [Member] | Maximum [Member]
     
Fair value of stock appreciation rights      
Risk Free Interest Rate 0.52% 0.83% 2.39%
Expected life (years) 4 years 5 years 6 years
Phantom Share Units (PSUs) [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 79,101    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 435,866    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (24,864)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (2,433)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 487,670    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 9.31    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 4.73    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 9.88    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 12.86    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 5.67